GENEMATRIX

The current price of 109820 is 2520 KRW — it has increased by 0.40% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange GENEMATRIX stocks are traded under the ticker 109820.

109820 stock is 1.59% volatile and has beta coefficient of 1.14. Check out the list of the most volatile stocks — is GENEMATRIX there?

Yes, you can track GENEMATRIX financials in yearly and quarterly reports right on TradingView.

109820 stock has risen by 0.60% compared to the previous week, the month change is a 17.92% fall, over the last year GENEMATRIX has showed a 52.63% decrease.

109820 net income for the last quarter is ‪−190.13 M‬ KRW, while the quarter before that showed ‪1.31 B‬ KRW of net income which accounts for −114.50% change. Track more GENEMATRIX financial stats to get the full picture.

No, 109820 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 109820 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENEMATRIX stock right from TradingView charts — choose your broker and connect to your account.

109820 reached its all-time high on Nov 20, 2020 with the price of 35500 KRW, and its all-time low was 990 KRW and was reached on Dec 4, 2013.
See other stocks reaching their highest and lowest prices.

As of Apr 24, 2024, the company has 65.00 employees. See our rating of the largest employees — is GENEMATRIX on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENEMATRIX technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENEMATRIX stock shows the sell signal. See more of GENEMATRIX technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENEMATRIX EBITDA is ‪−2.40 B‬ KRW, and current EBITDA margin is −20.01%. See more stats in GENEMATRIX financial statements.